NEJM Interview: Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency.

Kevin Outterson is a professor of health law, bioethics, and human rights at the Boston University School of Law. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. K. Outterson. Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules? N Engl J Med 2014;371:1-3.